Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick L Altice

Showing results (81-90 of 475) with videos related to

Pageof 48
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 2006
Models for integrating buprenorphine therapy into the primary HIV care settingSanjay Basu, Duncan Smith-Rohrberg, R Douglas Bruce, et al.
The International Journal on Drug Policy|January 20, 2026
Decolonizing addiction treatment in Eastern Europe and Central Asia: Confronting Russian narcology and Western retreatLyu Azbel, Mary Tate, Viktoria Akerø, et al.
AIDS and Behavior|December 8, 2017
Strategies to Implement Pre-exposure Prophylaxis with Men Who Have Sex with Men in UkraineAlex Dubov, Liana Fraenkel, Roman Yorick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2020
Modeling Combination Hepatitis C Virus Treatment and Prevention Strategies in a Network of People Who Inject Drugs in the United StatesAlexei Zelenev, Jianghong Li, Portia Shea, et al.
Contemporary Clinical Trials|January 4, 2014
Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the communitySandra A Springer, Frederick L Altice, Maua Herme, et al.
Plos One|January 26, 2016
Cost-Effectiveness of Single- Versus Generic Multiple-Tablet Regimens for Treatment of HIV-1 Infection in the United StatesDonna E Sweet, Frederick L Altice, Calvin J Cohen, et al.
AIDS and Behavior|November 13, 2020
Development and Psychometric Evaluation of the PrEP Sexual Expectancies (PSEXS) ScaleAlex Dubov, Adedotun Ogunbajo, Frederick L Altice, et al.
Journal of Substance Abuse Treatment|May 8, 2007
Pharmacological pain control for human immunodeficiency virus-infected adults with a history of drug dependenceSanjay Basu, R Douglas Bruce, Declan T Barry, et al.
JMIR Human Factors|July 15, 2025
Evaluating the Usability of an HIV Prevention Artificial Intelligence Chatbot in Malaysia: National Observational StudyZhao Ni, Sunyoung Oh, Rumana Saifi, et al.
Journal of Substance Abuse Treatment|February 17, 2016
An Exploratory Factor Analysis of a Brief Self-Report Scale to Detect Neurocognitive Impairment Among Participants Enrolled in Methadone Maintenance TherapyMichael Copenhaver, Roman Shrestha, Jeffrey A Wickersham, et al.
Pageof 48

Showing results (81-90 of 475) with videos related to

Sort By:
Pageof 48
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 2006
Models for integrating buprenorphine therapy into the primary HIV care settingSanjay Basu, Duncan Smith-Rohrberg, R Douglas Bruce, et al.
The International Journal on Drug Policy|January 20, 2026
Decolonizing addiction treatment in Eastern Europe and Central Asia: Confronting Russian narcology and Western retreatLyu Azbel, Mary Tate, Viktoria Akerø, et al.
AIDS and Behavior|December 8, 2017
Strategies to Implement Pre-exposure Prophylaxis with Men Who Have Sex with Men in UkraineAlex Dubov, Liana Fraenkel, Roman Yorick, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2020
Modeling Combination Hepatitis C Virus Treatment and Prevention Strategies in a Network of People Who Inject Drugs in the United StatesAlexei Zelenev, Jianghong Li, Portia Shea, et al.
Contemporary Clinical Trials|January 4, 2014
Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the communitySandra A Springer, Frederick L Altice, Maua Herme, et al.
Plos One|January 26, 2016
Cost-Effectiveness of Single- Versus Generic Multiple-Tablet Regimens for Treatment of HIV-1 Infection in the United StatesDonna E Sweet, Frederick L Altice, Calvin J Cohen, et al.
AIDS and Behavior|November 13, 2020
Development and Psychometric Evaluation of the PrEP Sexual Expectancies (PSEXS) ScaleAlex Dubov, Adedotun Ogunbajo, Frederick L Altice, et al.
Journal of Substance Abuse Treatment|May 8, 2007
Pharmacological pain control for human immunodeficiency virus-infected adults with a history of drug dependenceSanjay Basu, R Douglas Bruce, Declan T Barry, et al.
JMIR Human Factors|July 15, 2025
Evaluating the Usability of an HIV Prevention Artificial Intelligence Chatbot in Malaysia: National Observational StudyZhao Ni, Sunyoung Oh, Rumana Saifi, et al.
Journal of Substance Abuse Treatment|February 17, 2016
An Exploratory Factor Analysis of a Brief Self-Report Scale to Detect Neurocognitive Impairment Among Participants Enrolled in Methadone Maintenance TherapyMichael Copenhaver, Roman Shrestha, Jeffrey A Wickersham, et al.
Pageof 48